Literature DB >> 11210110

Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers.

M Tomita1, S Mizuno, H Yamanaka, Y Hosoda, K Sakuma, Y Matuoka, M Odaka, M Yamaguchi, H Yosida, H Morisawa, T Murayama.   

Abstract

A positive association between hyperuricemia and cardiovascular disease has been reported, but no study has evidenced yet the precise role of serum uric acid in the development of cardiovascular disease. In addition, no epidemiological studies have so far documented a decreased risk of cancer among people with hyperuricemia, even though the antioxidant action of uric acid has recently been stressed to inhibit DNA damage. The present prospective cohort study investigates the relationship between hyperuricemia and health hazards in a Japanese working population. The subjects were 49,413 Japanese male railroad workers, aged 25-60 years at enrollment. Serum uric acid and other baseline data were provided by annual health-survey records from 1975 to 1982. The vital status of the subjects was traced until the end of 1985 for those who remained alive. During an average 5.4-year study period, 984 deaths were recorded. Those with serum uric acid over 8.5 mg/dl showed elevated relative risks (RRs) of death in all causes (RR 1.62, p<0.01), coronary heart disease ( RR 1.52), stroke (RR 2.33, p<0.01), hepatic disease (RR 3.58, p<0.01), and renal failure ( RR 8.52, p<0.01), as compared with those with serum uric acid levels of 5.0-6.4mg/dl. The RR of death in all causes still remains statistically significant when adjusted by age and serum total cholesterol (2.00, p<0.01), age and alcohol intake (1.85, p<0.001), age and smoking (1.69, p<0.001), age and gout treatment (1.61, p<0.05), and also age and BMI (1.50, p< 0.05). On the other hand, the RR of all causes decreased but was still above 1.0 when adjusted by age and blood glucose (1.62), age and systolic blood pressure (1.32), age and GOT (1.23), and also age and history of cardiovascular disease (1.17). These results showed that hyperuricemia has a strong association with the RRs of death in all causes, coronary heart disease, stroke, hepatic disease and renal failure, and indicated that serum uric acid seems to be a considerable risk factor for reduced life expectancy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11210110     DOI: 10.2188/jea.10.403

Source DB:  PubMed          Journal:  J Epidemiol        ISSN: 0917-5040            Impact factor:   3.211


  51 in total

Review 1.  Urate reduction and renal preservation: what is the evidence?

Authors:  Nicolas Macías; Marian Goicoechea; M S García de Vinuesa; Ursula Verdalles; Jose Luño
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

Review 2.  Hyperuricemia and risk of stroke: a systematic review and meta-analysis.

Authors:  Seo Young Kim; James P Guevara; Kyoung Mi Kim; Hyon K Choi; Daniel F Heitjan; Daniel A Albert
Journal:  Arthritis Rheum       Date:  2009-07-15

3.  Longevity-associated NADH dehydrogenase subunit-2 237 Leu/Met polymorphism influences the effects of alcohol consumption on serum uric acid levels in nonobese Japanese men.

Authors:  Akatsuki Kokaze; Mamoru Ishikawa; Naomi Matsunaga; Masao Yoshida; Masao Satoh; Koji Teruya; Rie Honmyo; Misako Yorimitsu; Yumi Masuda; Yoshiko Uchida; Yutaka Takashima
Journal:  J Hum Genet       Date:  2006-08-08       Impact factor: 3.172

Review 4.  Effect of uric-acid-lowering therapy on progression of chronic kidney disease: a meta-analysis.

Authors:  Ye-Fang Zhang; Fan He; Hong-Hui Ding; Wei Dai; Qian Zhang; Hong Luan; Yong-Man Lv; Hong-Bing Zeng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-08-19

5.  Association of serum uric acid levels with the incident of kidney disease and rapid eGFR decline in Chinese individuals with eGFR > 60 mL/min/1.73 m2 and negative proteinuria.

Authors:  Fangfang Zhou; Geping Yu; Guoyu Wang; Yunzi Liu; Liwen Zhang; Weiming Wang; Nan Chen
Journal:  Clin Exp Nephrol       Date:  2019-02-08       Impact factor: 2.801

6.  Inactivation of nitric oxide by uric acid.

Authors:  Christine Gersch; Sergiu P Palii; Kyung Mee Kim; Alexander Angerhofer; Richard J Johnson; George N Henderson
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2008-08       Impact factor: 1.381

7.  Association of kidney disease with prevalent gout in the United States in 1988-1994 and 2007-2010.

Authors:  Stephen P Juraschek; Lara C Kovell; Edgar R Miller; Allan C Gelber
Journal:  Semin Arthritis Rheum       Date:  2013-01-09       Impact factor: 5.532

8.  Simultaneous determination of uric acid metabolites allantoin, 6-aminouracil, and triuret in human urine using liquid chromatography-mass spectrometry.

Authors:  Kyung Mee Kim; George N Henderson; Reginald F Frye; Cheryl D Galloway; Nancy J Brown; Mark S Segal; Witcha Imaram; Alexander Angerhofer; Richard J Johnson
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-11-25       Impact factor: 3.205

9.  Serum uric acid levels and mortality in the Japanese population: the Yamagata (Takahata) study.

Authors:  Keita Kamei; Tsuneo Konta; Kazunobu Ichikawa; Hiroko Sato; Natsuko Suzuki; Asami Kabasawa; Kazuko Suzuki; Atsushi Hirayama; Yoko Shibata; Tetsu Watanabe; Takeo Kato; Yoshiyuki Ueno; Takamasa Kayama; Isao Kubota
Journal:  Clin Exp Nephrol       Date:  2016-01-16       Impact factor: 2.801

10.  Elevated serum homocysteine levels for gouty patients.

Authors:  Tien-Tsai Cheng; Han-Ming Lai; Hsueh-Wen Chang; Shue-Fen Luo
Journal:  Clin Rheumatol       Date:  2004-09-16       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.